This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Party's Over for Small Caps, Stop Drinking the Punch

NEW YORK (TheStreet) -- Small caps are due for a pullback with large companies poised to take the lead. 

That's the assessment of many fund managers, after a record run for the Russell 2000 since the credit crisis. Over the past year, the index posted 25% against 20% for the S&P 500, with small cap valuations pushed to dizzying heights.

Now, fund managers are questioning whether earnings will justify such bloated multiples, with many forecasting single-digit returns for small companies in 2014.

"There's not a lot of bargains to be had among small companies and I'm very nervous about valuations on an absolute and relative basis," Bank of America Merrill Lynch head of small cap strategy Steven DeSanctis told a media briefing Tuesday.

He noted the forward price earnings ratio stood at 20 to 21 times for the sector, with recent outflows from small cap mutual funds. Against this valuation expansion, small cap earnings growth was only around 10% last year. "We are not going to see earnings kick into high gear -- it was a mixed reporting season and volatility has ticked up," DeSanctis added.

His commentary reflects that of many fund managers, who almost uniformly point to biotech and select pharmaceutical small cap stocks as low-quality risky plays, with several of them yet to generate earnings.

Russell Investments index investment strategist David Koenig also noted the more domestic revenue focus of small companies, which may see them at a relative disadvantage against the backdrop of a global economic recovery.

On a sector basis, DeSanctis likes global cyclical stocks, such as select industrial and technology companies. He is neutral on financials, which are initially hard-hit by a rising rates backdrop but ultimately benefit from a stronger economy -- preferring small banks, asset managers and insurers to real estate investment trusts. The fund manager is also neutral on health care, energy and material stocks, preferring chemicals and housing stocks. On the flip side, he avoids utilities, consumer staples and consumer discretionary stocks, with the latter having rallied hard over the past year.

More broadly, fund managers note investors are rewarding companies that participate in M&A as a use of cash on their balance sheets, with the share prices of both acquirers and targets often rising in recent deals. A tough backdrop for organic growth has seen a resurgence in M&A as macroeconomic uncertainty recedes, yet executives remain reluctant to invest heavily in new staff or infrastructure.

"We are underweight small caps for 2014 and it's mostly a valuation argument," DeSanctis said, ranking large, then mid-cap stocks above small companies for one-year return prospects.

The exception to this scenario would be a backdrop where the domestic economy improved faster than expected, causing an acceleration in earnings growth that would favor small caps over their large cap peers, the fund manager said.

 

-- By Jane Searle in New York

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $129.36 0.21%
FB $79.60 -0.19%
GOOG $573.64 0.40%
TSLA $199.56 1.13%
YHOO $42.62 -3.38%

Markets

DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs